Search Results - "Sebree T"

ZELRIX: a novel transdermal formulation of sumatriptan.

Authors: Pierce M Marbury T O'Neill C et al.

Source: Headache: The Journal of Head & Face Pain. Jun2009, Vol. 49 Issue 6, p817-825. 9p.

ST1 Caregiver-Perceived Behavioral Challenges in Fragile X Syndrome (FXS) and Their Measurement Using the Aberrant Behavior Checklist-Community FXS Specific (ABC-CFXS).

Authors: Merikle, E. Patel, V. Tich, N. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS241-S242. 2p.

PRO1 Meaningful Change Thresholds for the Aberrant Behavior Checklist-Community Fragile X Syndrome (ABC-CFXS) in Children and Adolescents with FXS.

Authors: Merikle, E. Patel, V. Dobbins, T. et al.

Source: Value in Health. 2021 Supplement 1, Vol. 24, pS197-S197. 1p.

Caregiver-perceived behavioral challenges in fragile X syndrome and implications for measuring treatment benefit in clinical trials.

Authors: Merikle E Tich N Sebree T et al.

Source: Journal of patient-reported outcomes [J Patient Rep Outcomes] 2026 Apr 01; Vol. 10 (1). Date of Electronic Publication: 2026 Apr 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Publishing Country of Publication: Germany NLM ID: 101722688 Publication Model: Electronic Cited Medium: Internet ISSN: 2509-8020 (Electronic) Linking ISSN: 25098020 NLM ISO Abbreviation: J Patient Rep Outcomes Subsets: MEDLINE

Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.

Authors: Berry-Kravis E Hagerman R Cohen J et al.

Source: Journal of neurodevelopmental disorders [J Neurodev Disord] 2025 Nov 18; Vol. 17 (1), pp. 69. Date of Electronic Publication: 2025 Nov 18.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE

Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial.

Authors: Scheffer IE Hulihan J Messenheimer J et al.

Source: JAMA network open [JAMA Netw Open] 2021 Sep 01; Vol. 4 (9), pp. e2123930. Date of Electronic Publication: 2021 Sep 01.

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.

Authors: Palumbo JM Thomas BF Budimirovic D et al.

Source: Journal of neurodevelopmental disorders [J Neurodev Disord] 2023 Jan 09; Vol. 15 (1), pp. 1. Date of Electronic Publication: 2023 Jan 09.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).

Authors: Berry-Kravis E Hagerman R Budimirovic D et al.

Source: Journal of neurodevelopmental disorders [J Neurodev Disord] 2022 Nov 25; Vol. 14 (1), pp. 56. Date of Electronic Publication: 2022 Nov 25.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE

The efficacy of transdermal sumatriptan is too low for general use - a response.

Authors: Goldstein J Smith T Pugach N et al.

Source: Headache [Headache] 2014 Jan; Vol. 54 (1), pp. 172-4.

Publication Type: Letter

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE

Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.

Authors: Pierce M O'Neill C Felker E et al.

Source: Headache [Headache] 2013 Sep; Vol. 53 Suppl 2, pp. 34-42.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE

A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.

Authors: Goldstein J Smith TR Pugach N et al.

Source: Headache [Headache] 2012 Oct; Vol. 52 (9), pp. 1402-10. Date of Electronic Publication: 2012 Jun 13.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.

Authors: Heussler H Cohen J Silove N et al.

Source: Journal of neurodevelopmental disorders [J Neurodev Disord] 2019 Aug 02; Vol. 11 (1), pp. 16. Date of Electronic Publication: 2019 Aug 02.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE

Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.

Authors: Zieba J Sinclair D Sebree T et al.

Source: Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2019 Jun; Vol. 181, pp. 93-100. Date of Electronic Publication: 2019 May 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0367050 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5177 (Electronic) Linking ISSN: 00913057 NLM ISO Abbreviation: Pharmacol Biochem Behav Subsets: MEDLINE

Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.

Authors: Bonn-Miller MO Banks SL Sebree T

Source: Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2017 Jan 01; Vol. 2 (1), pp. 5-7. Date of Electronic Publication: 2017 Jan 01 (Print Publication: 2017).

Publication Type: Journal Article

Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101684827 Publication Model: eCollection Cited Medium: Print ISSN: 2578-5125 (Print) Linking ISSN: 23788763 NLM ISO Abbreviation: Cannabis Cannabinoid Res Subsets: PubMed not MEDLINE

Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.

Authors: Merrick J Lane B Sebree T et al.

Source: Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2016 Apr 01; Vol. 1 (1), pp. 102-112. Date of Electronic Publication: 2016 Apr 01 (Print Publication: 2016).

Publication Type: Journal Article

Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101684827 Publication Model: eCollection Cited Medium: Print ISSN: 2578-5125 (Print) Linking ISSN: 23788763 NLM ISO Abbreviation: Cannabis Cannabinoid Res Subsets: PubMed not MEDLINE

A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.

Authors: Siegel SJ O'Neill C Dubé LM et al.

Source: Pharmaceutical research [Pharm Res] 2007 Oct; Vol. 24 (10), pp. 1919-26. Date of Electronic Publication: 2007 Jun 19.

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0724-8741 (Print) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

Authors: Steidle C Schwartz S Jacoby K et al.

Corporate Authors: Steidle C Schwartz S Jacoby K et al.

Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2003 Jun; Vol. 88 (6), pp. 2673-81.

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Print ISSN: 0021-972X (Print) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.

Authors: Marbury T Hamill E Bachand R et al.

Source: Biopharmaceutics & drug disposition [Biopharm Drug Dispos] 2003 Apr; Vol. 24 (3), pp. 115-20.

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7911226 Publication Model: Print Cited Medium: Print ISSN: 0142-2782 (Print) Linking ISSN: 01422782 NLM ISO Abbreviation: Biopharm Drug Dispos Subsets: MEDLINE

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

Authors: Zimbroff DL Kane JM Tamminga CA et al.

Source: The American journal of psychiatry [Am J Psychiatry] 1997 Jun; Vol. 154 (6), pp. 782-91.

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Psychiatric Association Country of Publication: United States NLM ID: 0370512 Publication Model: Print Cited Medium: Print ISSN: 0002-953X (Print) Linking ISSN: 0002953X NLM ISO Abbreviation: Am J Psychiatry Subsets: MEDLINE

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.

Authors: van Kammen DP McEvoy JP Targum SD et al.

Source: Psychopharmacology [Psychopharmacology (Berl)] 1996 Mar; Vol. 124 (1-2), pp. 168-75.

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print Cited Medium: Print ISSN: 0033-3158 (Print) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE